##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Project|Name|Name||Research/Institution|or Company|Project Status|Total Grant
Award|
|---|---|---|---|---|---|---|---|
|em Cells||||niversity ofMinnesota||ONGOING|140,000|
|Vitamin|B3|||Leiden Univetsity||Complete|10,000|
|acklin|fibrosis||and muscle re eneration|gada Biosciences||Terminated|25,000|
|||||Dr Olivier Dorchies||||
|Re u|osin|Dru|s|||ONGOING|25,000|
|||||University ofGeneva||||
|Project Name|Project Name||||||||Research/Institution
or Company|Project Status|Total Grant
Award|
|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||Dr Peter Arthur, Senior Lecturer|COMPLETE||
|aurine|||||||||e Univetuity
ofWestern Australia|018-2020|50,000|
||||||||||Dr Lee Borthwich,|ONGOING||
|Fibrosis|||||||||niversity ofNewcastle|2018-2019|KI0,000|
|ew wa sof delivmdn|||Gene||There||||EVOX Therapeutics|TERMINATE|200,000|
||||||||||rof Steve Winder|COMPLETE||
|nvestigating|soy products|||as|a treatment for DMD||||University ofSheffield|2018-2019|30,500|
|Preclinical|study|ofthe|combination|||oftamoxi fan, L-citrulline||and|Dr Olivier Dorchies|ONGOING|200,000|
|etfonnin|||||||||ntverstty ofGeneva|2018-2020||
||||||||||Dr Addolorata
Pisconti|COMPLETE||
|Use ofElastase||Inhibitors||toTreat DMD|||||University ofLive/pool|2017-2018|'36,365|
|sassing|the preclinical|||therapeutic||impact ofcannabidiol|for||Dr Keith Foster|COMPLETE|6213.09|
|MD|||||||||he Universi
ofReadin|2014-2016||
|e Duchcnne||Forum|||||||Muscular
Dystrophy
Campaign|COMPLETE|55,346|
|Su
ortin|8 basic research||||ro'acts|||||2014-2017||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||FORTH|E YEAR ENDED 30AP|RIL 2021||
|---|---|---|---|---|
||||30.4.21|30.420|
||||Unrestricted|Total|
||||fund|funds|
|||Notes|g||
|INCOME AND ENDOWMENTS FROM
Donations
and legacies|||44,590|151,844|
|Other trading activities
Investment
income|||142,423
155|217,852
586|
|Total|||187,168|370,282|
|EXPENDITURE ON
Raising funds|||68,323|152,992|
|Charitable
activities
Funding
research|||434,323|335,328|
|Other|||~277 073)|~747 312|
|Total|||225,573|1,235,632|
|NKT INCOME/(EXPENDITURE)|||(38,405)|(865,350)|
|RECONCILIATION|OF FUNDS||||
|Total funds brought|forward||2,993,539|3,858,889|
|TOTAL FUNDS CARRIED FORWARD|||~2955 134|~2993 539|
##
||BALANCE SHEET
30APRIL 2021|||
|---|---|---|---|
|||30.421|30.420|
|||Unrestricted|Total|
|||fund|funds|
||Notes|||
|FIXEDASSETS||||
|Tangible assets
Social investments|12
13|255
~592 60|318
~315187|
|||592,515|315,505|
|CURRENT ASSETS||||
|Stocks|14|322|322|
|Debtors|15|85|85|
|Cash at bank||~2367631|~2686 183|
|||2,368,038|2,686,590|
|CREDITORS||||
|Amounts
falling due within one year|16|(5,419)|(8,556)|
|NET CURRENT ASSETS||~2362619|~2678 034|
|TOTAL ASSETSLESSCURRENT||||
|LIABILITIES||2,955,134|2,993,539|
|NET ASSETS||~2 955 134|2 993539|
|FUNDS|17|||
|Unrestricted
funds||~2955 134|~2993 539|
|TOTAL FUNDS||~2 955 134|2 993539|
||||JOINING JACK|JOINING JACK|||
|---|---|---|---|---|---|---|
||||CASH FLOW STATEMENT||||
|||FORTHE YEARENDED 30APRIL 2021|||||
|||||30.421||30.4.20|
||||Notes|f.|||
|Cash flows from operating
activities
Cash generated
from operations||||~318706)||~119869)|
|Net cash used in opemting|activities|||~41|633)|119869|
|Cash flows*om investing|activities||||||
|Interest received|||||155|586|
|Dividends
received||||||~256 918|
|Net cash provided by investing||activities|||155|~257 504|
|Change in cash and cash|equivalents||in||||
|the reporting
period||||(318,552)||137,635|
|Cash and cash equivalents|at|the|||||
|beginning
ofthe reporting|period|||~2686|183|2 548 548|
|Cash and cash equivalents|at|the end|of||||
|the reporting
period||||2367637||~2686 183|
##
##
|ACTIVITPE1S||||
|---|---|---|---|
|||30.4.21|30,4.20|
||||f.|
|Net expenditure
for the reporting|period (as per the Statement of|||
|Financial Activities)
Adfustments for:||(38,405)|(865,350)|
|Depreciation
charges||64|80|
|Losses/(gain)
on investments
Interest received
Dividends
received
Decrease in stocks||(277,073)
(155)|1,000,816
(586)
(256,918)
8|
|(Decmase)/increase
in creditors||~3137|~2081|
|Net cash used in operations||~318706)|~119869)|
##
##
||At 1.5.20|Cash flow|At 30.4.21|
|---|---|---|---|
|Net cash||||
|Cash at bank|2 686 183|~318552)|2 367631|
||2 686 183|~318552)|~267631|
|Total|2 686 183|~318332|2367631|
##
##
##
##
##
##
##
##
##
##
##
|||||30.421|30.4.20|
|---|---|---|---|---|---|
||Donations|||~44 590|151844|
|3.|OTHER TRADING ACTIVITIES|||||
|||||30.421|30.4.20|
||Fundraising|events||142,423|217,672|
||Merchandise|sales|||180|
|||||~142 423|~217852|
|4.|INVESTMENT INCOME|||||
|||||30.4.21|30.4.20|
||||||g|
||Deposit account interest|||155|586|
||RAISING FUNDS|||||
||Raising donations||and legacies|||
|||||30.4.21|30.4.20|
||Statfcosts|||53,725|51,935|
||Rent|||2,400|2,400|
||Fundraising|costs||17,762|5,169|
||Travel costs||||3,142|
||Postage, stationery||and sundry|864|1,619|
||Computer costs|||1,986|1,572|
||Depreciation|||64|80|
||Government|Grants||(12,197)||
||Support costs|||4 630||
|||||~69 234|65917|
|6.|CHARITABLE ACTIVITIES COSTS|||||
||||||Grant|
||||||fundiag of|
||||||activities|
||||||(see note|
||||||7)|
||Funding research||||434323|
##
##
|7.|GRANTS|PAYABLE||||||
|---|---|---|---|---|---|---|---|
|||||||30.421|30.4.20|
||||||||g|
||Funding
research|||||~434 323|~335 328|
||The total grants paid to||institutions|during the year was as follows:||30.4.21|30.4.20|
||Newcastle
Duchenne|University
UK Grant Call||||434/23|15,328
200,000|
||Catabasis||||||100,000|
||Testosterone||||||10,000|
||Adult Hub||||||~10000|
|||||||~434 323|335328|
|8.|SUPPORT COSTS|||||||
||||||||Governance|
||||||||costs|
||Raising donations
and||legacies||||~4630|
||Support costs, included||in the above, are as follows:|||30.4.21|30.4.20|
|||||||Raising||
|||||||donations||
|||||||and|Total|
|||||||legac1es|activities|
||Auditom'|remuneration||||4,090|3,414|
||Auditors'|remuneration|for non audit work|||360||
||Accountancy
and legal||fees|||180||
|||||||~4630|~3414|
|9.|AUDITORS' REMUNERATION|||||30.4.21|30.420|
|||||||g||
||Fees payable to the charity's
auditors for the audit ofthe charity's
statements||||financial|4,090|3,414|
||Auditors'|remuneration|for non audit work|||360||
##
##
##
##
##
|11.|There were no truste
STAFF COSTS|es' expen|ses pa|id for th|e year|ended 30 April 2021 nor for t|he year ended 30|April 2020.|
|---|---|---|---|---|---|---|---|---|
||||||||30.421|30.420|
||Wages and salaries||||||~53 725|~51935|
||||||||~53 725|~51 935|
||The avemge monthly|number|ofemployees||during|the year was as follows:|||
||||||||30.4.21|30.4.20|
||Costs ofgenerating|voluntary|income||||2|2|
||Research and campaigning||||||1|1|
||||||||3||
||No employees
received emoluments|||in excess off60,000.|||||
|12.|TANGIBLE FIXEDASSETS||||||||
|||||||||Fixtures|
|||||||||and|
|||||||||Btiings|
||COST||||||||
||At 1 May 2020 and|30April|2021|||||~1461|
||DEPRECIATION||||||||
||At 1May 2020
Charge for year|||||||1,143
63|
||At 30April 2021|||||||~1206|
||NET BOOKVALUE||||||||
||At 30April 2021|||||||255|
||At 30April 2020|||||||318|
##
##
|STOCKS|||||
|---|---|---|---|---|
||||30.421|30.4.20|
||||322|322|
|DEBTORS:AMOUNTS FALLING DUE WITHIN ONE YEAR|||30.4.21|30.4.20|
||||g|g|
|Gitt Aid debtor|||85|85|
|CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR|||30.4.21|30.4.20|
|Trade creditors
Taxation and social security
Other creditors|||1,999
~3420|2,000
708
5 848|
||||~5419|~8556|
|MOVEMENT IN FUNDS|||||
||||Net||
||||movement|At|
|||At 1.5.20|iu funds|30.421|
|Unrestricted
funds|||||
|General fund|2,993,539||(38,405)|2,955,134|
|TOTAL FUNDS|2|993 539|~38405i|2955 134|
##
##
##
|||Incoming|Resources|Movement|
|---|---|---|---|---|
|||resources|expended|ln funds|
|||g|g||
|Unrestricted|funds||||
|General fund||187,168|(225,573)|(38,405)|
|TOTAL FUNDS||~187 168|~225 573)|~38405)|
##
||||Net||
|---|---|---|---|---|
||||movement|At|
|||At 1.5.19|in funds|30.4.20|
|Unrestricted|funds||||
|General fund||3,858,889|(865,350)|2,993,539|
|TOTAL FUNDS||3 858 889|~865350)|2 993539|
|||Incoming|Resources|Movement|
|---|---|---|---|---|
|||resources|expended|in funds|
|Unrestricted|funds||||
|General fund||370482|(1,235,632)|(865,350)|
|TOTAL FUNDS||~370
82|~1235632)|~865
50)|
||||Net||
|---|---|---|---|---|
||||movement|At|
|||At 1.5.19|in funds|30.4.21|
|Unrestricted|funds||||
|General fund||3,858,889|(903,755)|2,955,134|
|TOTAL FUNDS||3 858 889|~903755)|2 955 134|
##
##
|as follows:|||||
|---|---|---|---|---|
|||Incoming|Resources|Movement|
|||resollrces|expended|in funds|
||||g||
|Unrestricted|funds||||
|General fund||557,450|(1,461,205)|(903,755)|
|TOTAL FUNDS||~557 450|(1~461305)|~903755)|
##
##
##
|||FOR THE YEAR ENDED|30APRIL 2021||
|---|---|---|---|---|
||||30.421|30.420|
|INCOME AND ENDOWMENTS|||||
|Donations
and legacies|||||
|Donations|||44,590|151,844|
|Other trading activities|||||
|Fundraising
events
Merchandise
sales|||142,423|217,672
180|
||||142,423|217,852|
|Investment
income|||||
|Deposit account interest|||155|586|
|Total incoming resources|||187,168|370,282|
|EXPENDITURE|||||
|Raising donations
and|legacies||||
|Wages
Rent
Fundraising
costs
Travel costs
Postage, stationery
and sundry
Computer
costs
Depreciation offixtures and fittings
Government
Grants|||53,725
2,400
17,762
864
1,986
64
~12197)|51,935
2,400
5,169
3,142
1,619
1,572
80|
||||64,604|65 it17|
|Other trading
activities|||||
|Cost ofevents|||(911)|87,075|
|Charitable
activities|||||
|Grants to institutions|||434,323|335,328|
|Other|||||
|Impairment
losses for intangi3&le fixed||assets|(277,073)|743,898|
|Support costs|||||
|Governance
costs|||||
|Auditors'
remuneration
Auditors'
remuneration|for non-audit|wortc|4,090
360|3,414|
|Accountancy
and legal|fees||180||
||||4 630|3 414|
|Total resources expended|||~225 573|1 235632|
|Net expenditure|||~38405)|865350|